US President Signs New Trade Secrets Law 12/05/2016 by William New, Intellectual Property Watch Leave a Comment US President Barack Obama yesterday signed into law a measure aimed at strengthening trade secret protection including by allowing federal courts to hear cases involving trade secret theft.
Public Health Advocates Urge WHO Action On Alternative R&D Financing 12/05/2016 by William New, Intellectual Property Watch 2 Comments Public health advocates last week told World Health Organization delegates they must act quickly to save the lives of poor populations suffering from less common diseases for which there is no research and development funding. Nongovernmental organisations showed up to a WHO meeting on the issue to urge on delegates, even holding a public demonstration in front of the UN, but there was concern afterward at the little progress made.
Tech4Dev Conference: Translating Innovation Into Social Impact 11/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment New technologies are of limited value if they are not accessible. Thus the crucial challenge lies not only in promoting innovation, but in translating innovation into social impact. This was the theme of the fourth Conference on Technologies for Development (“Tech4Dev”).
At UN Indigenous Forum, WIPO Gives Update On Negotiations 10/05/2016 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization, a United Nations agency, today gave the UN in New York an update of ongoing negotiations for the protection of indigenous knowledge and genetic resources.
Document Explains Decision Granting Sovaldi Patent To Gilead 10/05/2016 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment A copy of the new Indian patent office order shows the details of the decision to reverse an earlier direction and grant a patent in India on the high-value hepatitis C drug. [Updated with response from Gilead]
As Patients Wait, WHO Members Chip Away At Decision On Medical R&D Funding 09/05/2016 by William New, Intellectual Property Watch 6 Comments A number of World Health Organization member states attended a meeting last week aimed finding ways to sustainably finance research and development for medical products, especially those for poor populations lacking means to pay high prices. According to the outcome document and a WHO official, they heard many viewpoints from experts and made progress but much was left for the World Health Assembly later this month.
Africa Should Speed Formation Of Pan-African IP Body, UN Report Says 05/05/2016 by Maina Waruru for Intellectual Property Watch 1 Comment NAIROBI, KENYA — A recent report by the United Nations Economic Commission for Africa (UNECA) is calling for faster establishment of a Pan-African Intellectual Property Organisation (PAIPO) to bring about what it sees as badly needed IP policy coherence on the continent.
Citing “Toxic” Environment, US Congress Members Urge Secretary Kerry To Get UN Report On WIPO 04/05/2016 by William New, Intellectual Property Watch Leave a Comment The bipartisan heads of several United States congressional subcommittees have sent a letter urging the Obama administration to obtain the full and uncensored United Nations report on an investigation into possible misconduct by the head of the World Intellectual Property Organization. Meanwhile, procedural wrangling may be taking place within WIPO on who has the right to suppress or see the report.
Alleged Leaked TTIP Report Reveals Differences, Convergence On IP Issues 03/05/2016 by William New, Intellectual Property Watch 2 Comments This week’s high-profile alleged leak of recent texts of the Transatlantic Trade and Investment Partnership (TTIP) negotiation between Europe and the United States sent a shockwave in policy circles. Below, Intellectual Property Watch highlights some of the IP-related elements in the text.
MSF Issues In-Depth Report On R&D And Drug Prices 02/05/2016 by Intellectual Property Watch 3 Comments Médecins Sans Frontières (MSF, Doctor Without Borders) today announced a report detailing what it calls failings in the current system for developing new drugs in ways that all patients can afford and access, and providing proposed policy options for addressing the problems.